Immuno-Oncology: a concept or already a reality?

Why are Immuno-Oncology compounds different?

Elderly population needs new definition to inform treatment decisions

Expert care is needed for elderly haematology patients

Aiding treatment of HIV and cancer with aspirin

ISIS 2 study: Use of aspirin to prevent cardiovascular problems

Engineering of polymeric nanoparticles for medical applications

The future of CLL treatment: balancing efficacy, safety and cost

Making sense of the expanding armoury of treatment options for the less fit CLL patient

‘Go-Go’ CLL patients: a look towards the future

The economic burden of CLL treatment now and in the future

Making sense of the expanding armoury of treatment options for the less fit patient